The augmented glenoid systems market is projected to grow from USD 808.1 million in 2026 to USD 1,681.0 million by 2036, at a CAGR of 7.6%. Metal augmented glenoids will dominate with a 56.0% market share, while primary shoulder arthroplasty will lead the application segment with a 61.0% share.